Guardant Health Stock Performance

GH Stock  USD 94.42  8.68  8.42%   
The company retains a Market Volatility (i.e., Beta) of 1.42, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Guardant Health will likely underperform. At this point, Guardant Health has a negative expected return of -0.18%. Please make sure to check out Guardant Health's sortino ratio, semi variance, and the relationship between the standard deviation and value at risk , to decide if Guardant Health performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Guardant Health has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unsteady performance, the Stock's technical indicators remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the firm traders. ...more

Actual Historical Performance (%)

One Day Return
(8.42)
Five Day Return
(12.95)
Year To Date Return
(7.19)
Ten Year Return
193.23
All Time Return
193.23
1
Disposition of 155 shares by Krognes Steve E. of Guardant Health subject to Rule 16b-3
11/28/2025
2
Disposition of 2000 shares by Kumud Kalia of Guardant Health at 104.6021 subject to Rule 16b-3
12/10/2025
3
Disposition of 23997 shares by Helmy Eltoukhy of Guardant Health subject to Rule 16b-3
12/31/2025
4
Disposition of tradable shares by Terilyn Monroe of Guardant Health at 113.4397 subject to Rule 16b-3
01/07/2026
5
Disposition of 17379 shares by Terilyn Monroe of Guardant Health subject to Rule 16b-3
01/15/2026
6
Acquisition by Hidalgo Medina Manuel of 232 shares of Guardant Health subject to Rule 16b-3
01/16/2026
7
Wall Street Has a Positive Opinion on Guardant Health
01/23/2026
8
Is Guardant Health Still Attractive After A 140 percent One Year Share Price Surge
02/04/2026
9
Acquisition by Kumud Kalia of 1995 shares of Guardant Health subject to Rule 16b-3
02/10/2026
10
Disposition of 3696 shares by Kumud Kalia of Guardant Health subject to Rule 16b-3
02/11/2026
11
Guardant Health Shares Slide as Principal Cuts Stake and Insiders Sell - Coinpaper
02/12/2026
12
Disposition of 250 shares by Tariq Musa of Guardant Health subject to Rule 16b-3
02/13/2026
13
What Makes Guardant Health a Good Healthcare Holding
02/17/2026
14
Guardant Health Non-GAAP EPS of -0.50 misses by 0.03, revenue of 281.3M beats by 9.02M
02/19/2026
15
BTIG Research Forecasts Strong Price Appreciation for Guardant Health Stock
02/20/2026
Begin Period Cash Flow629.8 M
Total Cashflows From Investing Activities-627.2 M

Guardant Health Relative Risk vs. Return Landscape

If you would invest  10,779  in Guardant Health on November 26, 2025 and sell it today you would lose (1,337) from holding Guardant Health or give up 12.4% of portfolio value over 90 days. Guardant Health is generating negative expected returns and assumes 2.9379% volatility on return distribution over the 90 days horizon. Put differently, 26% of stocks are less risky than Guardant on the basis of their historical return distribution, and some 99% of all equities are expected to be superior in generating returns on investments over the next 90 days.
  Expected Return   
       Risk  
Allowing for the 90-day total investment horizon Guardant Health is expected to under-perform the market. In addition to that, the company is 3.85 times more volatile than its market benchmark. It trades about -0.06 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.07 per unit of volatility.

Guardant Health Target Price Odds to finish over Current Price

The tendency of Guardant Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 94.42 90 days 94.42 
about 98.0
Based on a normal probability distribution, the odds of Guardant Health to move above the current price in 90 days from now is about 98.0 (This Guardant Health probability density function shows the probability of Guardant Stock to fall within a particular range of prices over 90 days) .
Allowing for the 90-day total investment horizon the stock has the beta coefficient of 1.42 . This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Guardant Health will likely underperform. Additionally Guardant Health has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Guardant Health Price Density   
       Price  

Predictive Modules for Guardant Health

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Guardant Health. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
91.3994.0796.75
Details
Intrinsic
Valuation
LowRealHigh
84.98107.25109.93
Details
Naive
Forecast
LowNextHigh
97.1499.82102.51
Details
24 Analysts
Consensus
LowTargetHigh
118.71130.45144.80
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Guardant Health. Your research has to be compared to or analyzed against Guardant Health's peers to derive any actionable benefits. When done correctly, Guardant Health's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Guardant Health.

Guardant Health Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Guardant Health is not an exception. The market had few large corrections towards the Guardant Health's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Guardant Health, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Guardant Health within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.09
β
Beta against Dow Jones1.42
σ
Overall volatility
5.48
Ir
Information ratio -0.02

Guardant Health Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Guardant Health for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Guardant Health can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Guardant Health generated a negative expected return over the last 90 days
The company generated the yearly revenue of 982.02 M. Annual Net Loss to common stockholders was (416.28 M) with gross profit of 633.01 M.
Guardant Health reports about 853.69 M in cash with (184.76 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.35.
Guardant Health has a poor financial position based on the latest SEC disclosures
Over 96.0% of the company shares are owned by institutional investors
Latest headline from thelincolnianonline.com: BTIG Research Forecasts Strong Price Appreciation for Guardant Health Stock

Guardant Health Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Guardant Stock often depends not only on the future outlook of the current and potential Guardant Health's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Guardant Health's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding125.4 M
Cash And Short Term Investments1.2 B

Guardant Health Fundamentals Growth

Guardant Stock prices reflect investors' perceptions of the future prospects and financial health of Guardant Health, and Guardant Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Guardant Stock performance.

About Guardant Health Performance

By evaluating Guardant Health's fundamental ratios, stakeholders can gain valuable insights into Guardant Health's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Guardant Health has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Guardant Health has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 89.81  69.23 
Return On Tangible Assets(0.22)(0.23)
Return On Capital Employed(0.26)(0.27)
Return On Assets(0.21)(0.22)
Return On Equity 4.19  4.40 

Things to note about Guardant Health performance evaluation

Checking the ongoing alerts about Guardant Health for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Guardant Health help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Guardant Health generated a negative expected return over the last 90 days
The company generated the yearly revenue of 982.02 M. Annual Net Loss to common stockholders was (416.28 M) with gross profit of 633.01 M.
Guardant Health reports about 853.69 M in cash with (184.76 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.35.
Guardant Health has a poor financial position based on the latest SEC disclosures
Over 96.0% of the company shares are owned by institutional investors
Latest headline from thelincolnianonline.com: BTIG Research Forecasts Strong Price Appreciation for Guardant Health Stock
Evaluating Guardant Health's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Guardant Health's stock performance include:
  • Analyzing Guardant Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Guardant Health's stock is overvalued or undervalued compared to its peers.
  • Examining Guardant Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Guardant Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Guardant Health's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Guardant Health's stock. These opinions can provide insight into Guardant Health's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Guardant Health's stock performance is not an exact science, and many factors can impact Guardant Health's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Guardant Stock analysis

When running Guardant Health's price analysis, check to measure Guardant Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Guardant Health is operating at the current time. Most of Guardant Health's value examination focuses on studying past and present price action to predict the probability of Guardant Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Guardant Health's price. Additionally, you may evaluate how the addition of Guardant Health to your portfolios can decrease your overall portfolio volatility.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges